目的:了解来立信治疗脑血管病气管切开术后肺部感染的疗效。方法:根据入院时间顺序将 40例院内感染,且对多种药物耐药的脑血管病气管切开术后患者随机分为两组,分别给予来立信 40 0mg/d或菌必治 2.0g/d治疗,疗程 7～ 14天。结果:来立信组与菌必治组的临床有效率分别是 90 %和 35 %,痊愈率分别是 6 0 %和 2 0 %,细菌清除率分别是 90 %和 45 %,不良反应发生率两组均为 5.0 %。结论:来立信对脑血管病气管切开术后肺部感染有肯定疗效。 Objective: To understand the effect of Lixin on pulmonary infection after tracheotomy of cerebrovascular disease. Methods: Forty patients with nosocomial infections and multiple drug-resistant cerebrovascular diseases after tracheostomy were randomly divided into two groups according to the admission time sequence: 40 cases of patients receiving Lixin or 2.0 g / d treatment, treatment 7 to 14 days. Results: The clinical effective rates of Lai Lixin and Dachang were 90% and 35% respectively, the cure rates were 60% and 20% respectively, and the bacterial clearance rates were 90% and 45% respectively. The incidence of adverse reactions was two Group were 5.0%. Conclusion: Ericsson has a definite effect on pulmonary infection after tracheotomy of cerebrovascular disease.